OVERVIEW

With several new drug and cellular therapies as well as an expansion of our understanding of the biologic heterogeneity of hematologic malignancies, there is a need for ongoing education in the area of hematologic malignancies. This interactive webinar series will focus on current best practices, and how those are evolving based on major updates in the biology, diagnosis, and management of hematologic malignancies. Attendee interaction is encouraged and promoted through the designated time for audience questions at the end of each webinar. Each 90-minute webinar will have two talks followed by discussion and audience Q&A. Presenters will include internationally-known disease experts from Mass General Cancer Center covering high-yield practice-changing updates in cellular therapies, transplant, myeloma, leukemia, and lymphoma.

SESSIONS:

March 27, 2024 - Myeloma
Speakers: Andrew Yee, MD & Diana Cirstea, MD

April 23, 2024 - Leukemia 
Speakers: Gaby Hobbs, MD & Andrew Brunner, MD

May 21, 2024 - Transplants
Speakers: Zachariah DeFilipp, MD & Richard Newcomb, MD

TARGET AUDIENCE

This activity is intended for physicians, nurses, pharmacists, other members of healthcare team (regional) with specialties such as general practice, hematology, hematology/oncology, medical oncology, primary care, and radiation oncology.

LEARNING OBJECTIVES

Upon completion of this activity, participants will be able to:

1. Describe new therapies available for hematologic malignancies.
2. Discuss practice-changing updates in the management of hematologic malignancies Consider new concepts in palliative care and survivorship.
3. Determine appropriate timing to consider transplant evaluation and cellular therapy referral for hematologic malignancies.
4. Discuss latest  and most promising disease-specific treatment options amongst the team to improve patient outcomes.

ACCREDITATION

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

AMA PRA Category 1 Credits^TM
Mass General Brigham designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.